CORCEPT THERAPEUTICS INC Deferred Income Tax Assets, Net
CORCEPT THERAPEUTICS INC (CORT) had Deferred Income Tax Assets, Net of $178.68 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-07-29
- 2026-06-30: Deferred Income Tax Assets, Net $178.68M.
- 2026-03-31: Deferred Income Tax Assets, Net $181.56M.
- 2025-12-31: Deferred Income Tax Assets, Net $168.20M.
- 2025-09-30: Deferred Income Tax Assets, Net $153.00M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $178.68M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $181.56M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $168.20M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $153.00M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $162.23M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $144.44M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $130.91M 10-K · filed 2026-02-24 |
| 2024-09-30 | $126.80M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $111.85M 10-Q · filed 2024-07-29 |
| 2024-03-31 | $97.87M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $90.61M 10-K · filed 2025-02-26 |
| 2023-09-30 | $87.10M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $78.21M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $68.00M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $61.47M 10-K · filed 2024-02-15 |
| 2022-09-30 | $57.34M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $48.49M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $37.71M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $27.45M 10-K · filed 2023-02-28 |
| 2021-09-30 | $29.64M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $33.74M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $37.02M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $31.60M 10-K · filed 2022-02-15 |
| 2020-09-30 | $33.82M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $35.47M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $40.56M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $45.68M 10-K · filed 2021-02-23 |
| 2019-09-30 | $50.80M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $56.70M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $61.68M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $62.66M 10-K · filed 2020-02-24 |
| 2017-12-31 | $76.70M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |